These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 1697646)

  • 41. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.
    Herrmann F; Lindemann A; Klein H; Lübbert M; Schulz G; Mertelsmann R
    Leukemia; 1989 May; 3(5):335-8. PubMed ID: 2654495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis.
    Bonilla MA; Gillio AP; Ruggeiro M; Kernan NA; Brochstein JA; Abboud M; Fumagalli L; Vincent M; Gabrilove JL; Welte K; Souza LM; O'Reilly RJ
    N Engl J Med; 1989 Jun; 320(24):1574-80. PubMed ID: 2471075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
    Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: a joint analysis of five randomised trials on behalf of the EWALL.
    Giebel S; Thomas X; Hallbook H; Geissler K; Boiron JM; Huguet F; Koller E; Jaeger U; Smedmyr B; Hellmann A; Holowiecki J
    Eur J Cancer; 2012 Feb; 48(3):360-7. PubMed ID: 22196969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group.
    Ohno R; Naoe T; Kanamaru A; Yoshida M; Hiraoka A; Kobayashi T; Ueda T; Minami S; Morishima Y; Saito Y
    Blood; 1994 Apr; 83(8):2086-92. PubMed ID: 7512838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent progress in the treatment of adult acute leukemia.
    Ohno R
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1287-93. PubMed ID: 2483486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
    Jakubowski AA; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla MA; Moore MA; Gabrilove J
    N Engl J Med; 1989 Jan; 320(1):38-42. PubMed ID: 2462670
    [No Abstract]   [Full Text] [Related]  

  • 48. A pilot study of the biologic and therapeutic effects of granulocyte colony-stimulating factor (filgrastim) in patients with acute myelogenous leukemia.
    Jakubowski A; Gordon M; Tafuri A; Schuster S; Andreeff M; Shieh JH; Vincent M; Gabrilove J
    Leukemia; 1995 Nov; 9(11):1799-804. PubMed ID: 7475265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report.
    Schroeder T; Hildebrandt B; Mayatepek E; Germing U; Haas R
    J Med Case Rep; 2008 Sep; 2():319. PubMed ID: 18826620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.
    Usuki K; Urabe A; Masaoka T; Ohno R; Mizoguchi H; Hamajima N; Miyazaki T; Niitsu Y; Yoshida Y; Miura A; Shibata A; Abe T; Miura Y; Ikeda Y; Nomura T; Nagao T; Saitou H; Shirakawa S; Ohkuma M; Matsuda T; Nakamura T; Horiuchi A; Kuramoto A; Kimura I; Irino S; Niho Y; Takatsuki K; Tomonaga M; Uchino H; Takaku F;
    Br J Haematol; 2002 Jan; 116(1):103-12. PubMed ID: 11841402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia.
    Liang DC; Chen SH; Lean SF
    Am J Hematol; 1995 Feb; 48(2):76-81. PubMed ID: 7531394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
    N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission.
    Kantarjian HM; Estey E; O'Brien S; Anaissie E; Beran M; Pierce S; Robertson L; Keating MJ
    Cancer; 1993 Nov; 72(10):2950-5. PubMed ID: 7693325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
    Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
    Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.
    Kang KW; Kim DS; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim BS; Park Y
    Leuk Res; 2017 Jun; 57():1-8. PubMed ID: 28231491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemia.
    Goto H; Shimazaki C; Hirata T; Ashihara E; Ohkawa K; Oku N; Inaba T; Fujita N; Nakagawa M
    Acta Haematol; 1993; 89(3):144-8. PubMed ID: 7689779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of colony-stimulating factors in acute leukemia.
    Holdsworth MT; Mathew P
    Ann Pharmacother; 2001 Jan; 35(1):92-108. PubMed ID: 11197591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of growth factors during induction therapy for acute myeloid leukemia.
    Rowe JM
    Leukemia; 1996 Apr; 10 Suppl 1():S40-3. PubMed ID: 8618471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
    Gabrilove JL; Jakubowski A; Fain K; Grous J; Scher H; Sternberg C; Yagoda A; Clarkson B; Bonilla MA; Oettgen HF
    J Clin Invest; 1988 Oct; 82(4):1454-61. PubMed ID: 2459163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report.
    Kobayashi Y; Okabe T; Ozawa K; Chiba S; Hino M; Miyazono K; Urabe A; Takaku F
    Am J Med; 1989 Feb; 86(2):178-82. PubMed ID: 2464280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.